Abstract
In January 1997, PCR genomic analysis of the TSG101 gene showed frequent large intragenic deletions. The investigators used a small cohort of sporadic breast cancers. Li et al. proposed human TSG 101 as a breast tumor supressor gene. Since then, several teams have worked on large series of breast cancers, using a variety of techniques. They have shown that intragenic deletion, if it exists at all, is rare. Is TSG101 a tumor gene or an impostor?.
Translated title of the contribution | Breast cancer: Is TSG101 a well named gene? |
---|---|
Original language | French |
Pages (from-to) | 1141-1142 |
Number of pages | 2 |
Journal | Bulletin du Cancer |
Volume | 84 |
Issue number | 12 |
Publication status | Published - 1 Dec 1997 |